Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Quick-Med Technologies, Inc. (QMDT)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Medical - Pharmaceuticals
Address
902 NW 4th Street 32601
Gainesville, FL, US
Gainesville, FL, US
CEO
Gerald Reisman
Website
quickmedtech.com
IPO
2002-10-16
ISIN US74837Q1067
Description
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The company’s core technologies include Nimbus, a non-leaching antimicrobial wound dressing material; Stay Fresh, a sequestered hydrogen peroxide-based antimicrobial technology; and superabsorbent antimicrobial materials. In addition, it offers bioguard, DriGo-HP, antimicrobial care products, antimicrobial textiles, and antimicrobial paints and coatings products. Quick-Med Technologies, Inc. was incorporated in 1997 and is headquartered in Gainesville, Florida.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
47
Beta
-55.91
Float Shares
31.10M
Free Float %
83.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +60.00% | +100.00% | +700.00% | +700.00% | +700.00% | +60.00% | -95.92% | -92.45% | -99.98% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-68.60
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%-6.9% Q2'13: -27.4% (vs Q2'12)
-
EPS growth Medical - Pharmaceuticals: +20.2%+57.7% ★ Q2'13: +53.3% (vs Q2'12)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%+44.1% Q2'13: -47.2% (vs Q2'12)
-
EBIT margin Medical - Pharmaceuticals: +6.8%-28.7% Q2'13: -23.7% (vs Q2'12)
-
ROIC Medical - Pharmaceuticals: +6.1%— Q2'13: +2.2% (vs Q2'12)
-
Share dilution Medical - Pharmaceuticals: +0.0%+0.0% Q2'13: +0.0% (vs Q2'12)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×-1.11× Q2'13: -0.85× (vs Q2'12)
Valuation Multiples
From
To
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.5K
OE per share TTM
0.00
Owner's Yield
-5.07%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-02-07 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 10,100 | 0.05 | 505.00 | 6,271,484 | — | ↗ |
| 2013-01-30 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,281,584 | — | ↗ |
| 2013-01-11 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 10,000 | 0.05 | 500.00 | 6,291,484 | — | ↗ |
| 2013-01-08 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 3,000 | 0.05 | 150.00 | 6,341,484 | — | ↗ |
| 2013-01-02 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,344,484 | — | ↗ |
| 2012-12-13 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,364,484 | — | ↗ |
| 2012-10-08 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Quick-Med Technologies, Inc. | 10,000 | 0.10 | 1.0K | 6,394,484 | — | ↗ |
| 2012-10-05 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Quick-Med Technologies, Inc. | 300 | 0.10 | 30.00 | 6,404,484 | — | ↗ |
| 2012-06-04 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 10,528 | 0.10 | 1.1K | 6,404,784 | — | ↗ |
| 2012-05-25 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 3,000 | 0.15 | 450.00 | 6,427,312 | — | ↗ |
| 2012-05-10 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,442,112 | — | ↗ |
| 2012-05-08 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 11,800 | 0.10 | 1.2K | 6,472,312 | — | ↗ |
| 2012-04-17 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,484,112 | — | ↗ |
| 2012-03-21 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,493,312 | — | ↗ |
| 2012-03-13 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 38,566 | 0.10 | 3.9K | 6,494,312 | — | ↗ |
| 2012-02-22 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 6,865 | 0.10 | 688.56 | 6,532,878 | — | ↗ |
| 2012-02-21 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 4,500 | 0.10 | 450.00 | 6,539,743 | — | ↗ |
| 2012-02-15 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 5,500 | 0.10 | 550.00 | 6,544,243 | — | ↗ |
| 2012-01-30 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,549,743 | — | ↗ |
| 2012-01-27 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 4,150 | 0.10 | 415.00 | 6,557,543 | — | ↗ |
| 2012-01-03 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 15,000 | 0.12 | 1.8K | 6,561,693 | — | ↗ |
| 2011-12-30 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 5,500 | 0.10 | 550.00 | 6,576,693 | — | ↗ |
| 2011-12-29 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 4,500 | 0.10 | 450.00 | 6,582,193 | — | ↗ |
| 2011-12-23 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 6,300 | 0.12 | 756.00 | 6,586,693 | — | ↗ |
| 2011-12-21 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 6,593 | — | ↗ |
| 2011-12-20 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 9,800 | 0.12 | 1.2K | 6,596,693 | — | ↗ |
| 2011-12-16 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 200 | 0.12 | 24.00 | 6,606,493 | — | ↗ |
| 2011-09-29 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 8,000 | 0.30 | 2.4K | 6,606,693 | — | ↗ |
| 2011-09-28 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per shar | 5,800 | 0.30 | 1.7K | 6,614,693 | — | ↗ |
| 2009-09-10 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 5,000 | 0.87 | 4.4K | 6,914,093 | — | ↗ |
| 2009-09-03 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 25,907 | 0.60 | 15.5K | 6,919,093 | — | ↗ |
| 2009-09-01 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 25,000 | 0.60 | 15.0K | 6,945,000 | — | ↗ |
| 2009-08-28 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 5,000 | 0.60 | 3.0K | 6,985,000 | — | ↗ |
| 2009-08-26 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 50,000 | 0.30 | 15.0K | 7,056,893 | — | ↗ |
| 2009-08-17 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 2,500 | 0.63 | 1.6K | 6,990,000 | — | ↗ |
| 2009-07-10 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 2,500 | 0.60 | 1.5K | 6,992,500 | — | ↗ |
| 2009-06-29 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 11,442 | 0.58 | 6.6K | 6,995,000 | — | ↗ |
| 2009-06-15 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 8,000 | 0.50 | 4.0K | 7,006,442 | — | ↗ |
| 2009-04-27 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 0 | 0.00 | — | 7,024,442 | — | ↗ |
| 2009-04-24 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 0 | 0.00 | — | 7,030,442 | — | ↗ |
| 2009-04-16 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 15,000 | 0.43 | 6.4K | 7,041,893 | — | ↗ |
| 2008-07-08 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock Par value $0.0001 | 40,000 | 0.35 | 14.0K | 7,091,078 | — | ↗ |
| 2008-05-29 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 0 | 0.00 | — | 7,131,078 | — | ↗ |
| 2008-05-28 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 0 | 0.00 | — | 7,136,078 | — | ↗ |
| 2008-05-27 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 0 | 0.00 | — | 7,141,078 | — | ↗ |
| 2008-05-21 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 0 | 0.00 | — | 7,166,078 | — | ↗ |
| 2008-05-14 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 5,815 | 0.29 | 1.7K | 7,171,893 | — | ↗ |
| 2008-05-13 | PHRONESIS PARTNERS L P | 10% Owner | S-Sale | D | Common Stock par value $0.0001 | 10,000 | 0.29 | 2.9K | 7,177,708 | — | ↗ |
| 2007-06-27 | PHRONESIS PARTNERS L P | 10% Owner | P-Purchase | A | Convertible Note | 0 | 0.74 | — | 506,757 | — | ↗ |
| 2006-12-20 | PHRONESIS PARTNERS L P | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 0 | 1.05 | — | 56,410 | — | ↗ |
| 2006-01-23 | TURNBULL CHERYL L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-12-02 | PHRONESIS PARTNERS L P | 10% Owner | P-Purchase | A | Common Stock Par Value $0.0001 | 13,795 | 0.62 | 8.6K | 7,187,708 | — | ↗ |
| 2004-12-31 | PHRONESIS PARTNERS L P | 10% Owner | X-InTheMoney | A | Common Stock, par value $0.0001 | 0 | 0.00 | — | 7,173,913 | — | ↗ |
| 2004-11-30 | PHRONESIS PARTNERS L P | 10% Owner | — | I | Common Stock, par value $0.0001 | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2003-07-24 | HUTT PETER BARTON | Director | A-Award | A | Common Stock | 26,000 | 0.00 | — | 224,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-53.4K
Shares Outstanding
37.35M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bernd Liesenfeld | Principal Executive Officer, President & Director | 126.1K | — |
| Gregory S. Schultz | Chairman & Scientific Advisor | 10.0K | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for QMDT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
